MYGN - Myriad Genetics Inc Revenue Breakdown

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: FLGT GRAL VCYT NTRA BLLN DGX LH A DHR TMO

| Held by: XBI IWM VTI IWN VXF FESM IBB FNDA SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.32	Insider Own	6.98%	Shs Outstand	94.40M	Perf Week	29.52%
Market Cap	555.36M	Forward P/E	38.91	EPS next Y	0.15	Insider Trans	2.11%	Shs Float	87.86M	Perf Month	49.62%
Enterprise Value	642.46M	PEG	0.59	EPS next Q	-0.06	Inst Own	93.64%	Short Float	9.85%	Perf Quarter	27.27%
Income	-399.90M	P/S	0.67	EPS this Y	2.08%	Inst Trans	-5.15%	Short Ratio	5.64	Perf Half Y	-10.37%
Sales	829.00M	P/B	1.65	EPS next Y	146.71%	ROA	-47.61%	Short Interest	8.65M	Perf YTD	-4.39%
Book/sh	3.57	P/C	4.46	EPS next 5Y	65.44%	ROE	-76.73%	52W High	8.59 -31.55%	Perf Year	10.32%
Cash/sh	1.32	P/FCF	-	EPS past 3/5Y	-41.67% -8.03%	ROIC	-73.81%	52W Low	3.53 66.57%	Perf 3Y	-74.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	6.72% 5.24%	Gross Margin	66.14%	Volatility	8.24% 7.58%	Perf 5Y	-81.97%
Dividend TTM	-	EV/Sales	0.77	EPS Y/Y TTM	-286.80%	Oper. Margin	-7.73%	ATR (14)	0.32	Perf 10Y	-80.40%
Dividend Ex-Date	-	Quick Ratio	2.19	Sales Y/Y TTM	-0.28%	Profit Margin	-48.24%	RSI (14)	75.15	Recom	2.89
Dividend Gr. 3/5Y	- -	Current Ratio	2.40	EPS Q/Q	-32981.82%	SMA20	28.26%	Beta	1.58	Target Price	6.38
Payout	-	Debt/Eq	0.63	Sales Q/Q	2.30%	SMA50	31.92%	Rel Volume	3.39	Prev Close	5.43
Employees	2700	LT Debt/Eq	0.61	Earnings	May 05 AMC	SMA200	1.00%	Avg Volume	1.53M	Price	5.88
IPO	Oct 06, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-32.35% -1.00%	Trades		Volume	5,197,798	Change	8.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)